Jinti Lin

555 total citations
10 papers, 375 citations indexed

About

Jinti Lin is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Jinti Lin has authored 10 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Jinti Lin's work include Immune cells in cancer (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (2 papers). Jinti Lin is often cited by papers focused on Immune cells in cancer (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (2 papers). Jinti Lin collaborates with scholars based in China. Jinti Lin's co-authors include Jiakang Jin, Ankai Xu, Chao Qian, Jianan Lou, Wei Yu, Yitian Wang, Xiumao Li, Huimin Tao, Wei Yu and Huimin Tao and has published in prestigious journals such as ACS Nano, Frontiers in Pharmacology and Chemico-Biological Interactions.

In The Last Decade

Jinti Lin

9 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinti Lin China 8 170 142 97 72 53 10 375
Jiakang Jin China 8 170 1.0× 140 1.0× 97 1.0× 72 1.0× 51 1.0× 10 375
András Piffkó Germany 10 144 0.8× 120 0.8× 81 0.8× 91 1.3× 27 0.5× 24 369
Kyeongah Kang South Korea 10 245 1.4× 119 0.8× 96 1.0× 63 0.9× 38 0.7× 16 481
Christina Hipfinger United States 5 131 0.8× 138 1.0× 148 1.5× 50 0.7× 73 1.4× 6 378
Siyuan Hou China 11 135 0.8× 159 1.1× 103 1.1× 96 1.3× 39 0.7× 17 430
Chunyang Zhang China 10 91 0.5× 190 1.3× 101 1.0× 59 0.8× 89 1.7× 21 417
Yiting Feng China 5 277 1.6× 178 1.3× 194 2.0× 66 0.9× 70 1.3× 15 523

Countries citing papers authored by Jinti Lin

Since Specialization
Citations

This map shows the geographic impact of Jinti Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinti Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinti Lin more than expected).

Fields of papers citing papers by Jinti Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinti Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinti Lin. The network helps show where Jinti Lin may publish in the future.

Co-authorship network of co-authors of Jinti Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jinti Lin. A scholar is included among the top collaborators of Jinti Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinti Lin. Jinti Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lin, Jinti, et al.. (2025). Pulsatilla saponin D inhibited the growth of osteosarcoma by regulating the JNK/ATF3 signaling pathway. Chemico-Biological Interactions. 410. 111420–111420.
2.
Yu, Wei, Jinti Lin, Tao Yu, et al.. (2023). The regulation of N6‐methyladenosine modification in PD‐L1‐induced anti‐tumor immunity. Immunology and Cell Biology. 101(3). 204–215. 2 indexed citations
3.
Qu, Liyan, Jiakang Jin, Jianan Lou, et al.. (2022). The nuclear transportation of PD-L1 and the function in tumor immunity and progression. Cancer Immunology Immunotherapy. 71(10). 2313–2323. 11 indexed citations
4.
Jin, Jiakang, Pengcheng Yuan, Wei Yu, et al.. (2022). Mitochondria-Targeting Polymer Micelle of Dichloroacetate Induced Pyroptosis to Enhance Osteosarcoma Immunotherapy. ACS Nano. 16(7). 10327–10340. 118 indexed citations
5.
Lin, Jinti, Ankai Xu, Jiakang Jin, et al.. (2022). MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression. OncoImmunology. 11(1). 2024941–2024941. 65 indexed citations
6.
Zhang, Man, Jinti Lin, Jiakang Jin, et al.. (2021). Delivery of siRNA Using Functionalized Gold Nanorods Enhances Anti-Osteosarcoma Efficacy. Frontiers in Pharmacology. 12. 799588–799588. 12 indexed citations
7.
Wang, Tiecheng, Jiakang Jin, Chao Qian, et al.. (2021). Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment. Cancer Cell International. 21(1). 295–295. 28 indexed citations
8.
Zhang, Man, Yang Bai, Chang Xu, et al.. (2021). Novel optimized drug delivery systems for enhancing spinal cord injury repair in rats. Drug Delivery. 28(1). 2548–2561. 19 indexed citations
9.
Jin, Jiakang, Jinti Lin, Ankai Xu, et al.. (2021). CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment. Frontiers in Oncology. 11. 111 indexed citations
10.
Xu, Ankai, Chao Qian, Jinti Lin, et al.. (2021). Cell Differentiation Trajectory-Associated Molecular Classification of Osteosarcoma. Genes. 12(11). 1685–1685. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026